SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-067755
Filing Date
2018-11-13
Accepted
2018-11-13 08:48:52
Documents
6
Period of Report
2018-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-39866_18k.htm 8-K 32592
2 EX-1.1 a18-39866_1ex1d1.htm EX-1.1 223202
3 EX-5.1 a18-39866_1ex5d1.htm EX-5.1 13417
4 GRAPHIC g398661kii001.jpg GRAPHIC 2026
5 GRAPHIC g398661kii002.jpg GRAPHIC 1577
6 GRAPHIC g398661kii003.jpg GRAPHIC 6063
  Complete submission text file 0001104659-18-067755.txt   284144
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 181175434
SIC: 2834 Pharmaceutical Preparations